Table 1.

Principal qualitative aspects of nonsteroidal anti-inflammatory drugs (NSAIDs).

Drug	Target	Half Time	Milk Withdrawal
Salicylate	COX-1/2	0.5 h	24 h
Flunexin meglumine	COX-1 preferential	1.6 h	36–48 h
Meloxicam	COX-2 preferential	26 h	120 h (0.5 mg/kg BW, i.m.) or 80 h (1 mg/kg BW, os)
Carprofen	COX-2 selective	30.7 h	Not required 1

¹ in European countries; i.m.: intramuscular; os: oral.